Our present study, for the first time, revealed the roles played SP/NK-1R and LOC389641/TNFRSF10A in the PNI of pancreatic cancer cells and might provide some novel biomarkers for monitoring the effect of pancreatic cancer therapy. This evidence concerns the gene TFF2 and familial pancreatic carcinoma.